This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen acción BLU
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de BELLUS Health Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$19.50 |
| 52 Week High | CA$19.90 |
| 52 Week Low | CA$8.58 |
| Beta | -0.28 |
| 1 Month Change | -1.42% |
| 3 Month Change | 100.82% |
| 1 Year Change | 50.70% |
| 3 Year Change | 38.79% |
| 5 Year Change | 962.09% |
| Change since IPO | -97.95% |
Noticias y actualizaciones recientes
Recent updates
BELLUS Health (TSE:BLU) Is In A Good Position To Deliver On Growth Plans
Jan 16
Here's Why We're Not Too Worried About BELLUS Health's (TSE:BLU) Cash Burn Situation
Sep 07We're Hopeful That BELLUS Health (TSE:BLU) Will Use Its Cash Wisely
May 05Here's Why We're Watching BELLUS Health's (TSE:BLU) Cash Burn Situation
Jan 06Companies Like BELLUS Health (TSE:BLU) Are In A Position To Invest In Growth
Sep 10Rentabilidad de los accionistas
| BLU | CA Biotechs | Mercado CA | |
|---|---|---|---|
| 7D | 0.5% | 0.4% | -1.5% |
| 1Y | 50.7% | -31.2% | 4.7% |
Rentabilidad vs. Industria: BLU exceeded the Canadian Biotechs industry which returned 23.5% over the past year.
Rentabilidad vs. Mercado: BLU exceeded the Canadian Market which returned 0.8% over the past year.
Volatilidad de los precios
| BLU volatility | |
|---|---|
| BLU Average Weekly Movement | 28.1% |
| Biotechs Industry Average Movement | 14.3% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Precio estable de las acciones: BLU's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: BLU's weekly volatility has increased from 16% to 28% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1993 | 74 | Roberto Bellini | www.bellushealth.com |
Resumen de fundamentos de BELLUS Health Inc.
| Estadísticas fundamentales de BLU | |
|---|---|
| Capitalización bursátil | CA$2.47b |
| Beneficios(TTM) | -CA$115.02m |
| Ingresos (TTM) | CA$19.88k |
Over9,999x
Ratio precio-ventas (PS)-21.5x
Ratio precio-beneficio (PE)¿Está BLU sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BLU | |
|---|---|
| Ingresos | US$15.00k |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$15.00k |
| Otros gastos | US$86.80m |
| Beneficios | -US$86.79m |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.68 |
| Margen bruto | 100.00% |
| Margen de beneficio neto | -578,586.67% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado BLU a largo plazo?
Ver rendimiento histórico y comparativa